APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Osimertinib Industry Growth and Trends Forecast to 2032

23 December 202598 pages

Choose your research edition.

Industry ResearchOsimertinib Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Osimertinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Osimertinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osimertinib include Beacon Pharma, Drug International, Everest Pharmaceuticals, Incepta Pharmaceuticals Limited and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Osimertinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Osimertinib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Osimertinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Osimertinib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Osimertinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Osimertinib Market by Company

Beacon Pharma

Drug International

Everest Pharmaceuticals

Incepta Pharmaceuticals Limited

AstraZeneca

Osimertinib Segment by Type

80mg*30 Tablets

80mg*10 Tablets

40mg*30 Tablets

40mg*10 Tablets

Osimertinib Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Others

Osimertinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osimertinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Osimertinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 80mg*30 Tablets Table 2. Major Company of 80mg*10 Tablets Table 3. Major Company of 40mg*30 Tablets Table 4. Major Company of 40mg*10 Tablets Table 5. Global Osimertinib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Osimertinib Sales by Type (2021-2026) & (k pcs) Table 7. Global Osimertinib Sales Market Share in Volume by Type (2021-2026) Table 8. Global Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 9. Global Osimertinib Sales Market Share in Value by Type (2021-2026) Table 10. Global Osimertinib Price by Type (2021-2026) & (US$/pcs) Table 11. Global Osimertinib Sales by Type (2027-2032) & (k pcs) Table 12. Global Osimertinib Sales Market Share in Volume by Type (2027-2032) Table 13. Global Osimertinib Sales by Type (2027-2032) & (US$ Million) Table 14. Global Osimertinib Sales Market Share in Value by Type (2027-2032) Table 15. Global Osimertinib Price by Type (2027-2032) & (US$/pcs) Table 16. North America Osimertinib Sales by Type (2021-2026) & (k pcs) Table 17. North America Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Osimertinib Sales by Type (2021-2026) & (k pcs) Table 19. Europe Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Osimertinib Sales by Type (2021-2026) & (k pcs) Table 21. Asia-Pacific Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Osimertinib Sales by Type (2021-2026) & (k pcs) Table 23. Latin America Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Osimertinib Sales by Type (2021-2026) & (k pcs) Table 25. Middle East and Africa Osimertinib Sales by Type (2021-2026) & (US$ Million) Table 26. Osimertinib Industry Trends Table 27. Osimertinib Industry Drivers Table 28. Osimertinib Industry Opportunities and Challenges Table 29. Osimertinib Industry Restraints Table 30. Global Osimertinib Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Osimertinib Revenue Market Share by Company (2021-2026) Table 32. Global Osimertinib Sales by Company (2021-2026) & (k pcs) Table 33. Global Osimertinib Sales Share by Company (2021-2026) Table 34. Global Osimertinib Market Price by Company (2021-2026) & (US$/pcs) Table 35. Global Osimertinib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Osimertinib Major Company Production Sites and Headquarters Table 37. Global Osimertinib Company, Product Type & Application Table 38. Global Osimertinib Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Osimertinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Osimertinib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Osimertinib Sales by Region (2021-2026) & (k pcs) Table 43. Global Osimertinib Sales Market Share in Volume by Region (2021-2026) Table 44. Global Osimertinib Sales by Region (2021-2026) & (US$ Million) Table 45. Global Osimertinib Sales Market Share in Value by Region (2021-2026) Table 46. Global Osimertinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 47. Global Osimertinib Sales by Region (2027-2032) & (k pcs) Table 48. Global Osimertinib Sales Market Share in Volume by Region (2027-2032) Table 49. Global Osimertinib Sales by Region (2027-2032) & (US$ Million) Table 50. Global Osimertinib Sales Market Share in Value by Region (2027-2032) Table 51. Global Osimertinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 52. Global Osimertinib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Osimertinib Sales by Application (2021-2026) & (k pcs) Table 54. Global Osimertinib Sales Market Share in Volume by Application (2021-2026) Table 55. Global Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 56. Global Osimertinib Sales Market Share in Value by Application (2021-2026) Table 57. Global Osimertinib Price by Application (2021-2026) & (US$/pcs) Table 58. Global Osimertinib Sales by Application (2027-2032) & (k pcs) Table 59. Global Osimertinib Sales Market Share in Volume by Application (2027-2032) Table 60. Global Osimertinib Sales by Application (2027-2032) & (US$ Million) Table 61. Global Osimertinib Sales Market Share in Value by Application (2027-2032) Table 62. Global Osimertinib Price by Application (2027-2032) & (US$/pcs) Table 63. North America Osimertinib Sales by Application (2021-2026) & (k pcs) Table 64. North America Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Osimertinib Sales by Application (2021-2026) & (k pcs) Table 66. Europe Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Osimertinib Sales by Application (2021-2026) & (k pcs) Table 68. Asia-Pacific Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Osimertinib Sales by Application (2021-2026) & (k pcs) Table 70. Latin America Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Osimertinib Sales by Application (2021-2026) & (k pcs) Table 72. Middle East and Africa Osimertinib Sales by Application (2021-2026) & (US$ Million) Table 73. Beacon Pharma Company Information Table 74. Beacon Pharma Business Overview Table 75. Beacon Pharma Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. Beacon Pharma Osimertinib Product Portfolio Table 77. Beacon Pharma Recent Development Table 78. Drug International Company Information Table 79. Drug International Business Overview Table 80. Drug International Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Drug International Osimertinib Product Portfolio Table 82. Drug International Recent Development Table 83. Everest Pharmaceuticals Company Information Table 84. Everest Pharmaceuticals Business Overview Table 85. Everest Pharmaceuticals Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. Everest Pharmaceuticals Osimertinib Product Portfolio Table 87. Everest Pharmaceuticals Recent Development Table 88. Incepta Pharmaceuticals Limited Company Information Table 89. Incepta Pharmaceuticals Limited Business Overview Table 90. Incepta Pharmaceuticals Limited Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 91. Incepta Pharmaceuticals Limited Osimertinib Product Portfolio Table 92. Incepta Pharmaceuticals Limited Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 96. AstraZeneca Osimertinib Product Portfolio Table 97. AstraZeneca Recent Development Table 98. North America Osimertinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 99. North America Osimertinib Sales by Country (2021-2026) & (k pcs) Table 100. North America Osimertinib Sales Market Share by Country (2021-2026) Table 101. North America Osimertinib Sales Forecast by Country (2027-2032) & (k pcs) Table 102. North America Osimertinib Sales Market Share Forecast by Country (2027-2032) Table 103. North America Osimertinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Osimertinib Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Osimertinib Market Share by Country (2021-2026) Table 106. North America Osimertinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Osimertinib Market Share Forecast by Country (2027-2032) Table 108. Europe Osimertinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 109. Europe Osimertinib Sales by Country (2021-2026) & (k pcs) Table 110. Europe Osimertinib Sales Market Share by Country (2021-2026) Table 111. Europe Osimertinib Sales Forecast by Country (2027-2032) & (k pcs) Table 112. Europe Osimertinib Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Osimertinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Osimertinib Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Osimertinib Market Share by Country (2021-2026) Table 116. Europe Osimertinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Osimertinib Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Osimertinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Osimertinib Sales by Country (2021-2026) & (k pcs) Table 120. Asia-Pacific Osimertinib Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Osimertinib Sales Forecast by Country (2027-2032) & (k pcs) Table 122. Asia-Pacific Osimertinib Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Osimertinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Osimertinib Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Osimertinib Market Share by Country (2021-2026) Table 126. Asia-Pacific Osimertinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Osimertinib Market Share Forecast by Country (2027-2032) Table 128. Latin America Osimertinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 129. Latin America Osimertinib Sales by Country (2021-2026) & (k pcs) Table 130. Latin America Osimertinib Sales Market Share by Country (2021-2026) Table 131. Latin America Osimertinib Sales Forecast by Country (2027-2032) & (k pcs) Table 132. Latin America Osimertinib Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Osimertinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Osimertinib Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Osimertinib Market Share by Country (2021-2026) Table 136. Latin America Osimertinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Osimertinib Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Osimertinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Osimertinib Sales by Country (2021-2026) & (k pcs) Table 140. Middle East and Africa Osimertinib Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Osimertinib Sales Forecast by Country (2027-2032) & (k pcs) Table 142. Middle East and Africa Osimertinib Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Osimertinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Osimertinib Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Osimertinib Market Share by Country (2021-2026) Table 146. Middle East and Africa Osimertinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Osimertinib Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Osimertinib Distributors List Table 151. Osimertinib Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Osimertinib Image Figure 2. Global Osimertinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Sales (2021-2032) & (k pcs) Figure 5. 80mg*30 Tablets Image Figure 6. Global 80mg*30 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 80mg*10 Tablets Image Figure 8. Global 80mg*10 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 9. 40mg*30 Tablets Image Figure 10. Global 40mg*30 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 11. 40mg*10 Tablets Image Figure 12. Global 40mg*10 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 13. Global Osimertinib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Osimertinib Market Share by Type 2025 VS 2032 Figure 15. North America Osimertinib Sales Market Share in Volume by Type in 2025 Figure 16. North America Osimertinib Sales Market Share in Value by Type in 2025 Figure 17. Europe Osimertinib Sales Market Share in Volume by Type in 2025 Figure 18. Europe Osimertinib Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Osimertinib Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Osimertinib Sales Market Share in Value by Type in 2025 Figure 21. Latin America Osimertinib Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Osimertinib Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Osimertinib Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Osimertinib Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Osimertinib Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Locally Advanced NSCLC Image Figure 28. Global Locally Advanced NSCLC Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Metastatic NSCLC Image Figure 30. Global Metastatic NSCLC Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 33. Global Osimertinib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Osimertinib Market Share by Application 2025 VS 2032 Figure 35. North America Osimertinib Sales Market Share in Volume by Application in 2025 Figure 36. North America Osimertinib Sales Market Share in Value by Application in 2025 Figure 37. Europe Osimertinib Sales Market Share in Volume by Application in 2025 Figure 38. Europe Osimertinib Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Osimertinib Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Osimertinib Sales Market Share in Value by Application in 2025 Figure 41. Latin America Osimertinib Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Osimertinib Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Osimertinib Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Osimertinib Sales Market Share in Value by Application in 2025 Figure 45. North America Osimertinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 46. North America Osimertinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Osimertinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Osimertinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Osimertinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 50. Europe Osimertinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Osimertinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Osimertinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Osimertinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 54. Asia-Pacific Osimertinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Osimertinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Osimertinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Osimertinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 58. Latin America Osimertinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Osimertinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Osimertinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Osimertinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 62. Middle East and Africa Osimertinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Osimertinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Osimertinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Osimertinib Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Osimertinib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg*30 Tablets
  • 80mg*10 Tablets
  • 40mg*30 Tablets
  • 40mg*10 Tablets
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
  • Others
Companies covered
  • Beacon Pharma
  • Drug International
  • Everest Pharmaceuticals
  • Incepta Pharmaceuticals Limited
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osimertinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Osimertinib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Osimertinib Market by Type
  6. 1.3.1 80mg*30 Tablets
  7. 1.3.2 80mg*10 Tablets
  8. 1.3.3 40mg*30 Tablets
  9. 1.3.4 40mg*10 Tablets
  10. 1.4 Global Osimertinib Market Size by Type
  11. 1.4.1 Global Osimertinib Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Osimertinib Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Osimertinib Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Osimertinib Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Osimertinib Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Osimertinib Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Osimertinib Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Osimertinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Osimertinib Industry Trends
  2. 2.2 Osimertinib Industry Drivers
  3. 2.3 Osimertinib Industry Opportunities and Challenges
  4. 2.4 Osimertinib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Osimertinib Revenue (2021-2026)
  2. 3.2 Global Top Players by Osimertinib Sales (2021-2026)
  3. 3.3 Global Top Players by Osimertinib Price (2021-2026)
  4. 3.4 Global Osimertinib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osimertinib Major Company Production Sites & Headquarters
  6. 3.6 Global Osimertinib Company, Product Type & Application
  7. 3.7 Global Osimertinib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osimertinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osimertinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osimertinib Tier 1, Tier 2, and Tier 3
4 Osimertinib Regional Status and Outlook
  1. 4.1 Global Osimertinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Osimertinib Historic Market Size by Region
  3. 4.2.1 Global Osimertinib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Osimertinib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Osimertinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Osimertinib Forecasted Market Size by Region
  7. 4.3.1 Global Osimertinib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Osimertinib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Osimertinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Osimertinib by Application
  1. 5.1 Osimertinib Market by Application
  2. 5.1.1 Locally Advanced NSCLC
  3. 5.1.2 Metastatic NSCLC
  4. 5.1.3 Others
  5. 5.2 Global Osimertinib Market Size by Application
  6. 5.2.1 Global Osimertinib Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Osimertinib Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Osimertinib Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Osimertinib Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Osimertinib Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Osimertinib Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Osimertinib Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Osimertinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Beacon Pharma
  2. 6.1.1 Beacon Pharma Company Information
  3. 6.1.2 Beacon Pharma Business Overview
  4. 6.1.3 Beacon Pharma Osimertinib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Beacon Pharma Osimertinib Product Portfolio
  6. 6.1.5 Beacon Pharma Recent Developments
  7. 6.2 Drug International
  8. 6.2.1 Drug International Company Information
  9. 6.2.2 Drug International Business Overview
  10. 6.2.3 Drug International Osimertinib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Drug International Osimertinib Product Portfolio
  12. 6.2.5 Drug International Recent Developments
  13. 6.3 Everest Pharmaceuticals
  14. 6.3.1 Everest Pharmaceuticals Company Information
  15. 6.3.2 Everest Pharmaceuticals Business Overview
  16. 6.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Everest Pharmaceuticals Osimertinib Product Portfolio
  18. 6.3.5 Everest Pharmaceuticals Recent Developments
  19. 6.4 Incepta Pharmaceuticals Limited
  20. 6.4.1 Incepta Pharmaceuticals Limited Company Information
  21. 6.4.2 Incepta Pharmaceuticals Limited Business Overview
  22. 6.4.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Incepta Pharmaceuticals Limited Osimertinib Product Portfolio
  24. 6.4.5 Incepta Pharmaceuticals Limited Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Osimertinib Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Osimertinib Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Osimertinib Sales by Country
  2. 7.1.1 North America Osimertinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Osimertinib Sales by Country (2021-2026)
  4. 7.1.3 North America Osimertinib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Osimertinib Market Size by Country
  6. 7.2.1 North America Osimertinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Osimertinib Market Size by Country (2021-2026)
  8. 7.2.3 North America Osimertinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Osimertinib Sales by Country
  2. 8.1.1 Europe Osimertinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Osimertinib Sales by Country (2021-2026)
  4. 8.1.3 Europe Osimertinib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Osimertinib Market Size by Country
  6. 8.2.1 Europe Osimertinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Osimertinib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Osimertinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Osimertinib Sales by Country
  2. 9.1.1 Asia-Pacific Osimertinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Osimertinib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Osimertinib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Osimertinib Market Size by Country
  6. 9.2.1 Asia-Pacific Osimertinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Osimertinib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Osimertinib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Osimertinib Sales by Country
  2. 10.1.1 South America Osimertinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Osimertinib Sales by Country (2021-2026)
  4. 10.1.3 South America Osimertinib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Osimertinib Market Size by Country
  6. 10.2.1 South America Osimertinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Osimertinib Market Size by Country (2021-2026)
  8. 10.2.3 South America Osimertinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Osimertinib Sales by Country
  2. 11.1.1 Middle East and Africa Osimertinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Osimertinib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Osimertinib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Osimertinib Market Size by Country
  6. 11.2.1 Middle East and Africa Osimertinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Osimertinib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Osimertinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Osimertinib Value Chain Analysis
  2. 12.1.1 Osimertinib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Osimertinib Production Mode & Process
  7. 12.2 Osimertinib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Osimertinib Distributors
  10. 12.2.3 Osimertinib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst